| Structure | Chemical Name | CAS | MF |
|
3-(2-chlorobenzylamino)-2-benzhydrylquinuclidine
|
135007-72-6
|
C27H29ClN2
|
|
1-N-BUTYL-2-METHYL-4-NITROIMIDAZOLE
|
135009-57-3
|
C8H13N3O2
|
|
2,7-Dihydroxy-6-methoxy-5H-phenanthro[4,5-bcd]pyran-5-one
|
135010-49-0
|
|
|
9,10-Dihydro-2,7-dihydroxy-6-methoxy-5H-phenanthro[4,5-bcd]pyran-5-one
|
135010-50-3
|
C16H12O5
|
|
agaveside C
|
135010-58-1
|
C62H102O31
|
|
pedicularioside A
|
135010-61-6
|
C34H44O19
|
|
ethyl(R)-6-hydroxy-3-methylhexanoate
|
135011-13-1
|
C9H18O3
|
|
1-methyl-3-propylimidazole-2-thione
|
135011-47-1
|
C7H12N2S
|
|
2-hydroxy-2-trifluoromethyloctadec-4-enoic acid
|
135014-48-1
|
C19H33F3O3
|
|
phenylalanyl-threonyl-arginyl-phenylalaninamide
|
135014-49-2
|
|
|
4-Ethoxyamphetamine
|
135014-85-6
|
C11H17NO
|
|
1-(4-Ethoxyphenyl)propan-2-aMine hydrochloride
|
135014-87-8
|
C11H18ClNO
|
|
2-Butylquinolin-4(1H)-One(WXC01675)
|
135015-64-4
|
C13H15NO
|
|
2-ethyl-4-hydroxyquinoline-6-carbonitrile
|
135016-07-8
|
C12H10N2O
|
|
Guanidine, N-[(2-chloro-5-thiazolyl)methyl]-N'-nitro-
|
135018-15-4
|
C5H6ClN5O2S
|
|
Formaldehyde, polymer with 1,3-benzenediol and ethenylbenzene
|
135020-80-3
|
C15H16O3
|
|
2'-O-Methyl-N2-methylguanosine
|
135023-21-1
|
C12H17N5O5
|
|
1,4-CYCLOHEXANEDIMETHANOL DILAURATE
|
135025-34-2
|
C32H60O4
|
|
thiokynurenate
|
135025-53-5
|
C10H7NO2S
|
|
7-CHLORO-4-MERCAPTOQUINOLINE-2-CARBOXYLIC ACID HCL
|
135025-56-8
|
C10H6ClNO2S
|
|
5,7-DICHLOROTHIOKYNURENIC ACID
|
135025-62-6
|
C10H5Cl2NO2S
|
|
ETHYL 2-DIMETHYLAMINO-4-TRIFLUOROMETHYL-5-THIAZOLECARBOXYLATE
|
135026-10-7
|
C9H11F3N2O2S
|
|
ETHYL 2-[(1,1-DIMETHYLETHYL)AMINO]-4-TRIFLUOROMETHYL-5-OXAZOLECARBOXYLATE
|
135026-14-1
|
C11H15F3N2O3
|
|
2-AMINO-4-TRIFLUOROMETHYL-OXAZOLE-5-CARBOXYLIC ACID ETHYL ESTER
|
135026-17-4
|
C7H7F3N2O3
|
|
ethyl 2-(isopropylamino)-4-(trifluoromethyl)-1,3-thiazole-5-carboxylate
|
135026-49-2
|
C10H13F3N2O2S
|
|
D-MYO-INOSITOL 1,5,6-TRIS-PHOSPHATE AMMONIUM SALT
|
135027-58-6
|
C6H18NO15P3
|
|
D-MYO-INOSITOL 3,4,5,6-TETRAKIS-PHOSPHATE AMMONIUM SALT
|
135027-59-7
|
C6H19NO18P4
|
|
ibuprofenyl-coenzyme A
|
135027-64-4
|
C34H52N7O17P3S
|
|
L-660711
|
135028-15-8
|
|
|
trans-1-Methyl-5-oxo-2-(3-pyridinyl)-3-pyrrolidinecarboxylic Acid Methyl Ester
|
135028-97-6
|
C12H14N2O3
|
|
R-N,N,N',N'-tetramethyl-1,1'-binaphthyldiamine
|
135029-77-5
|
C24H24N2
|
|
2H-Pyran-3(6H)-one, 6-hydroxy-2-(hydroxymethyl)- (9CI)
|
135029-81-1
|
C6H8O4
|
|
2-Piperidinone,3-amino-4,5-dihydroxy-,[3R-(3alpha,4beta,5alpha)]-(9CI)
|
135030-05-6
|
C5H10N2O3
|
|
3-Chloro-6-iodopyridazine
|
135034-10-5
|
C4H2ClIN2
|
|
4-((methylsulfonyl)amino)-N-((4-phenylpiperazin-2-yl)methyl)benzamide
|
135036-03-2
|
C19H24N4O3S
|
|
1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-((4-p-nitrobenzol)-1-piperazinyl)quinoline-3-carboxylic acid
|
135038-30-1
|
C23H21FN4O6
|
|
glycopril
|
135038-56-1
|
C22H23NO6S
|
|
Fasidotril
|
135038-57-2
|
C23H25NO6S
|
|
ALATRIOPRILAT
|
135038-59-4
|
C14H17NO5S
|
|
TRIBUTYL(TRIFLUOROMETHYL)STANNANE
|
135039-77-9
|
C13H27F3Sn
|
|
1-(METHOXYMETHYL)-1H-INDOLE-3-CARBOXYLIC ACID
|
135039-80-4
|
C11H11NO3
|
|
N-[3-(1,5-Disulfonaphthyl)]-N''-[4-(2,2,6,6-tetramethylpiperidine-N-oxide)]-
|
135040-05-0
|
C20H24N3O7S3*2Na
|
|
Bicyclo[3.1.0]hexan-3-ol, 1-ethynyl-2-methylene-, [1S-(1alpha,3alpha,5alpha)]- (9CI)
|
135041-02-0
|
C9H10O
|
|
2-Amino-6-chloro-[(4-methylphenyl)thio]-9-(2’,3’,5’-tri-O-acetyl--D-ribofuranosyl)purine
|
135041-23-5
|
C23H25N5O7S
|
|
6-[(4-Methylphenyl)thio]-2-oxo-9-(2’,3’,5’-tri-O-acetyl--D-ribofuranosyl)-2,3-dihydropurine
|
135041-24-6
|
C23H24N4O8S
|
|
(2R,4R)-N-Boc-4-hydroxypyrrolidine-2-carboxylic acid
|
135042-12-5
|
C10H17NO5
|
|
N-tert-Butoxycarbonyl-trans-(p-toluenesulfonyloxy)-L-prolinol
|
135042-14-7
|
C17H25NO6S
|
|
N-Boc-Trans-4-Hydroxy-D-proline methyl ester
|
135042-17-0
|
C11H19NO5
|
|
HYDROQUINIDINE 9-PHENANTHRYL ETHER
|
135042-88-5
|
C34H34N2O2
|
|
HYDROQUINIDINE 4-METHYL-2-QUINOLYL ETHER
|
135042-89-6
|
C30H33N3O2
|
|
N-DescyclopropylMethyl-N-Methoxycarbonyl-6,8-dehydro-3-O-Methyl Naltrexone
|
135042-90-9
|
C19H19NO5
|
|
HYDROXYETHYLAMINOMETHYL-p-AMINOPHENOL HCL
|
135043-63-9
|
C9H15ClN2O2
|
|
2-AMINOMETHYL-P-AMINOPHENOL 2HCL
|
135043-64-0
|
C7H12Cl2N2O
|
|
2-METHOXYMETHYL-p-AMINOPHENOL HCL
|
135043-65-1
|
C8H12ClNO2
|
|
Clopidogrel hydrogen sulfate
|
135046-48-9
|
C16H18ClNO6S2
|
|
incarnal
|
135048-13-4
|
C15H16O3
|
|
(4S,5R)-4β,10β-Dihydroxy-3-methylene-6β-[(E)-1-propenyl]-2-oxaspiro[4.5]dec-7-ene-1,9-dione
|
135048-14-5
|
C13H14O5
|
|
4-Pyridinecarboxylicacid,2-cyano-,hydrazide(9CI)
|
135048-32-7
|
C7H6N4O
|
|
alpha-methylmilacemide
|
135048-42-9
|
C8H18N2O
|
|
4(1H)-Pteridinone,2-amino-4a,5,6,7,8,8a-hexahydro-6-methyl-(9CI)
|
135048-53-2
|
C7H13N5O
|
|
2,6-Bis(bis-(2-chloroethyl)amino)-4,8-dipiperidino-pyrimido(5,4-d)pyrimidine
|
135048-70-3
|
C24H36Cl4N8
|
|
FSH-beta-(51-65)
|
135048-75-8
|
C79H125N19O23S
|
|
4-(3-BROMOPHENYL)-TETRAHYDRO-2H-PYRAN-4-OL
|
135048-94-1
|
C11H13BrO2
|
|
1-Iodo-4-isopropoxy-benzene
|
135049-82-0
|
C9H11IO
|
|
2-chloro-4-iodobenzyl bromide
|
135049-84-2
|
C7H5BrClI
|
|
N-(2-CHLORO-4-IODOPHENYL)ACETAMIDE
|
135050-05-4
|
C8H7ClINO
|
|
3-CHLORO-4-IODOANILINE
|
135050-44-1
|
C6H5ClIN
|
|
2-Chloro-4-(1H-imidazol-1-yl)-6-methylpyrimidine
|
135052-25-4
|
C8H7ClN4
|
|
3-isoisoguanosine 5'-phospho-2-methylimidazole
|
135052-69-6
|
C14H18N7O7P
|
|
3-ribofuranosylisoguanosine 5'-diphosphate
|
135052-71-0
|
C10H15N5O11P2
|
|
CIS-1-AMINO-INDAN-2-CARBOXYLIC ACID HYDROCHLORIDE
|
135053-09-7
|
C10H12ClNO2
|
|
cis-2-Amino-1-cyclopentanecarboxamide
|
135053-11-1
|
C6H12N2O
|
|
Cyclopentanecarboxamide, 2-amino-N-methyl-, (1R,2S)-rel- (9CI)
|
135053-13-3
|
C7H14N2O
|
|
CIS-1-AMINO-INDAN-2-CARBOXYLIC ACID
|
135053-20-2
|
C10H11NO2
|
|
2-Pyridinecarboxylic acid, 4-(chlorocarbonyl)-, methyl ester (9CI)
|
135054-67-0
|
C8H6ClNO3
|
|
(5-chloropyridin-2-yl)pyridin-2-ylamine
|
135056-04-1
|
C10H8ClN3
|
|
2H-1,3-Dithiolo[4,5-c]coumarine, 2-dicyanomethylene-8-nitro-
|
135056-17-6
|
C13H3N3O4S2
|
|
insulin, His(B16)-
|
135059-20-0
|
|
|
glycoprotein B, infectious laryngotracheitis virus
|
135060-54-7
|
|
|
Repaglinide
|
135062-02-1
|
C27H36N2O4
|
|
fluoroclorgyline
|
135062-18-9
|
C13H15ClFNO
|
|
2,4-Pentadienoic acid, 4-hydroxy- (9CI)
|
135064-15-2
|
C5H6O3
|
|
5-methoxy-N-propyl-2,3,4,4a,9,9a-hexahydro-1-H-indeno(2,1-c)pyridine
|
135064-20-9
|
C16H23NO
|
|
6-Chloro-7-hydroxy-3,4-dimethyl-2H-chromen-2-one
|
135065-47-3
|
C11H9ClO3
|
|
Carbamic acid, (1-ethyl-3-hydroxypropyl)-, 1,1-dimethylethyl ester (9CI)
|
135065-68-8
|
C10H21NO3
|
|
2-HYDROXYMETHYL-4-BOC-MORPHOLINE
|
135065-69-9
|
C10H19NO4
|
|
(R)-2-((benzyloxy)methyl)morpholine(WXC06858)
|
135065-70-2
|
C12H17NO2
|
|
(R)-N-Boc-2-Hydroxymethylmorpholine
|
135065-71-3
|
C10H19NO4
|
|
(S)-N-Boc-2-Hydroxymethylmorpholine
|
135065-76-8
|
C10H19NO4
|
|
4-TERT-BUTOXYPHENYLACETIC ACID
|
135066-21-6
|
C12H16O3
|
|
1H-IMIDAZOLE-1-ETHANAMINE, HYDROBROMIDE
|
135066-25-0
|
C5H10BrN3
|
|
2,3-Pyridinediamine, 4-propyl-
|
135070-77-8
|
C8H13N3
|
|
2-Morpholinecarboxamide, 4-(phenylmethyl)-
|
135072-12-7
|
C12H16N2O2
|
|
2-morpholinecarboxamide(SALTDATA: HCl)
|
135072-13-8
|
C5H10N2O2
|
|
4-BENZYL-2-MORPHOLINECARBONYL CHLORIDE HYDROCHLORIDE
|
135072-14-9
|
C12H15Cl2NO2
|
|
4-BENZYL-2-MORPHOLINECARBOXYLIC ACID HYDROCHLORIDE
|
135072-15-0
|
C12H16ClNO3
|
|
2-Morpholinecarboxamide,N-methyl-(9CI)
|
135072-21-8
|
C6H12N2O2
|
|
2-Morpholinecarboxamide,N-ethyl-(9CI)
|
135072-22-9
|
C7H14N2O2
|
|
2-Morpholinecarboxamide,N,N-dimethyl-(9CI)
|
135072-23-0
|
C7H14N2O2
|
|
2-(morpholin-2-yl)acetamide
|
135072-28-5
|
C6H12N2O2
|